Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reappraising the role of inflammation in heart failure
Luigi Adamo, Cibele Rocha‐Resende, Sumanth D. Prabhu, et al.
Nature Reviews Cardiology (2020) Vol. 17, Iss. 5, pp. 269-285
Closed Access | Times Cited: 557

Showing 1-25 of 557 citing articles:

2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Katja Zeppenfeld, Jacob Tfelt‐Hansen, Marta Riva, et al.
European Heart Journal (2022) Vol. 43, Iss. 40, pp. 3997-4126
Closed Access | Times Cited: 1677
Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies
Stefan Frantz, Moritz Hundertmark, Jeanette Schulz‐Menger, et al.
European Heart Journal (2022) Vol. 43, Iss. 27, pp. 2549-2561
Open Access | Times Cited: 302
Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure
Anis Hanna, Nikolaos G. Frangogiannis
Cardiovascular Drugs and Therapy (2020) Vol. 34, Iss. 6, pp. 849-863
Open Access | Times Cited: 292
From Systemic Inflammation to Myocardial Fibrosis
Walter J. Paulus, Michael R. Zile
Circulation Research (2021) Vol. 128, Iss. 10, pp. 1451-1467
Open Access | Times Cited: 210
Cardiovascular Disease Risk Among Cancer Survivors
Roberta Florido, Natalie Daya, Chiadi E. Ndumele, et al.
Journal of the American College of Cardiology (2022) Vol. 80, Iss. 1, pp. 22-32
Open Access | Times Cited: 147
CCL17 Aggravates Myocardial Injury by Suppressing Recruitment of Regulatory T Cells
Guoshuai Feng, Geetika Bajpai, Pan Ma, et al.
Circulation (2022) Vol. 145, Iss. 10, pp. 765-782
Open Access | Times Cited: 77
Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions
Nicola Riccardo Pugliese, Pierpaolo Pellicori, Francesco Filidei, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 18, pp. 3536-3555
Open Access | Times Cited: 73
Targeting Iron Metabolism and Ferroptosis as Novel Therapeutic Approaches in Cardiovascular Diseases
Yufei Chen, Xueting Li, Siyuan Wang, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 591-591
Open Access | Times Cited: 61
The traditional Chinese medicines treat chronic heart failure and their main bioactive constituents and mechanisms
Jie Chen, Xiao‐Hong Wei, Qian Zhang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 5, pp. 1919-1955
Open Access | Times Cited: 50
ALKBH5-mediated m6A modification of IL-11 drives macrophage-to-myofibroblast transition and pathological cardiac fibrosis in mice
Tao Zhuang, Meihua Chen, Ruo-Xi Wu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 26
Integrative Single-Cell Analysis of Cardiomyopathy Identifies Differences in Cell Stemness and Transcriptional Regulatory Networks among Fibroblast Subpopulations
Wenyang Nie, Zhijie Zhao, Liu Y, et al.
Cardiology Research and Practice (2024) Vol. 2024, pp. 1-22
Open Access | Times Cited: 24
The Associations of Two Novel Inflammation Biomarkers, SIRI and SII, with Mortality Risk in Patients with Chronic Heart Failure
Di Zhu, Chi Wang, You Zhou, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 1255-1264
Open Access | Times Cited: 20
Monascus pigment-protected bone marrow-derived stem cells for heart failure treatment
Tian Yue, Wentai Zhang, Haifeng Pei, et al.
Bioactive Materials (2024) Vol. 42, pp. 270-283
Open Access | Times Cited: 20
Triple Hybrid Cellular Nanovesicles Promote Cardiac Repair after Ischemic Reperfusion
Jialin Lai, Qi Pan, Guihao Chen, et al.
ACS Nano (2024) Vol. 18, Iss. 5, pp. 4443-4455
Closed Access | Times Cited: 19
Immune checkpoints in cardiac physiology and pathology: therapeutic targets for heart failure
Tamás G. Gergely, Zsófia D. Drobni, Marinos Kallikourdis, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 7, pp. 443-462
Closed Access | Times Cited: 15
Flavonoids: Potential therapeutic agents for cardiovascular disease
Yingxue Liu, Jing Luo, Peng Lin, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32563-e32563
Open Access | Times Cited: 15
Inflammation in Obesity-Related HFpEF
Subodh Verma, Mark C. Petrie, Barry A. Borlaug, et al.
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 17, pp. 1646-1662
Open Access | Times Cited: 15
Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fraction
Danielle Rasooly, Claudia Giambartolomei, Gina M. Peloso, et al.
Nature Cardiovascular Research (2025)
Closed Access | Times Cited: 2
Inflammation in Human Heart Failure: Major Mediators and Therapeutic Targets
Marta Reina‐Couto, Patrícia Pereira‐Terra, Janete Quelhas‐Santos, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 91
Metformin as an anti-inflammatory agent: a short review
Robin Kristófi, Jan W. Eriksson
Journal of Endocrinology (2021) Vol. 251, Iss. 2, pp. R11-R22
Open Access | Times Cited: 81
MCC950 attenuates doxorubicin-induced myocardial injury in vivo and in vitro by inhibiting NLRP3-mediated pyroptosis
Lei Zhang, Yuehua Jiang, Cundong Fan, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112133-112133
Open Access | Times Cited: 76
The evolving cardiac lymphatic vasculature in development, repair and regeneration
Konstantinos Klaourakis, Joaquim Miguel Vieira, Paul R. Riley
Nature Reviews Cardiology (2021) Vol. 18, Iss. 5, pp. 368-379
Open Access | Times Cited: 71
Macrophage AXL receptor tyrosine kinase inflames the heart after reperfused myocardial infarction
Matthew DeBerge, Kristofor Glinton, Manikandan Subramanian, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 6
Open Access | Times Cited: 68
The impact of SGLT2 inhibitors on inflammation: A systematic review and meta-analysis of studies in rodents
Panagiotis Theofilis, Μarios Sagris, Evangelos Oikonomou, et al.
International Immunopharmacology (2022) Vol. 111, pp. 109080-109080
Closed Access | Times Cited: 64
Clonal hematopoiesis in cardiovascular disease and therapeutic implications
Alan R. Tall, José J. Fuster
Nature Cardiovascular Research (2022) Vol. 1, Iss. 2, pp. 116-124
Open Access | Times Cited: 61
Page 1 - Next Page

Scroll to top